Verition Fund Management’s Maze Therapeutics MAZE Stock Holding History
Bought
Maintained
Sold
Other funds holding MAZE
Verition Fund Management's MAZE Position: Q3 2026 in Review
Verition Fund Management sold out of Maze Therapeutics (MAZE) in Q3 2026, closing a stake of 18,201 shares — an estimated $543K sold.
Verition Fund Management first reported a position in MAZE in Q4 2025 and held it in 3 quarters. The position peaked at $933K in Q4 2025. 158 funds tracked by Wall St. Rank hold MAZE as of Q3 2026.
- Verition Fund Management reported no remaining Maze Therapeutics position as of Q3 2026 after selling out during the quarter.
- Verition Fund Management sold 18,201 Maze Therapeutics shares in Q3 2026, an estimated $543K.
- Verition Fund Management first reported a position in Maze Therapeutics in Q4 2025 and held it in 3 quarters.
- Verition Fund Management's Maze Therapeutics position peaked at $933K in Q4 2025.
- 158 funds tracked by Wall St. Rank held Maze Therapeutics as of Q3 2026.
Based on Verition Fund Management's 13F filing for Q3 2026, filed 13 Nov 2026.